ONCY

0.350110.37%
TC

Thomas C. Heineman

Chief Medical Officer

Dr. Thomas C. Heineman, also known as Tom, M.D., Ph.D., serves as Chief Medical Officer at Oncolytics Biotech Inc. since December 21, 2021. Dr. Heineman served as a Global Head of Clinical Development and Operations at Oncolytics Biotech Inc since August 3, 2020 until December 21, 2021. Dr. Heineman has extensive experience leading clinical development at biotech companies, most recently serving as Senior Vice President and Head of Clinical Development at Denovo Biopharma. Prior to his time at Denovo, Dr. Heineman served as Vice President and Head of Clinical Development at Genocea Biosciences and Halozyme Therapeutics, where he was also the Head of Translational Medicine. His experience further extends into big pharma and academia, as he has previously held roles as Senior Director, Global Clinical Research and Development at GlaxoSmithKline and as an Associate Professor at the Saint Louis University School of Medicine. He completed his fellowship in Infectious Diseases at the National Institutes of Health and his internship and residency at the University of Maryland. Dr. Heineman earned his MD in Virology at the University of Chicago, where he also received a PhD in molecular genetics & in Virology.

Positions